Search fresh public links, source activity, and ready-to-use post angles for Glp-1S.
Fresh curated links around GLP-1s are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects.
Recent studies suggest the weight loss and diabetes drugs may prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brai...
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide...
Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabe...
WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...
GLP-1 medications and hormone therapies have moved from niche to mainstream. About 19% of large employers now cover GLP-1 drugs used primarily for weight loss, according to the Kai...
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide...
Experts are intrigued by the theory. Here’s what early research suggests.
These drugs are quickly proving to go way beyond weight loss.
Scientists have identified a new way to supercharge the GLP-1 receptor agonist semaglutide, opening the door to boosting the drug's weight-loss power and helping long-term users pu...
GLP-1 receptor agonists, particularly new generation agents such as semaglutide and tirzepatide, may significantly reduce the risk for arthroplasty in patients with knee osteoarthr...
Since GLP-1 drugs like Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide took the world by storm for their potent treatment of diabetes and obesity, they have also been plague...
GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?
NEW ORLEANS — Individuals with obesity and autoimmune diseases who use a GLP-1 receptor agonist may have lower risk for mortality, fewer cardiovascular and thrombotic events and lo...
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, researchers report.
The different medications work to help regulate appetite and blood sugar levels.
Currently, two generic versions of Ozempic and Wegovy are available for Canadians to purchase for patients who use it to treat diabetes or weight loss for a fraction of the cost.
Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.
What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...
GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?
Adults taking GLP-1 receptor agonists alongside multiple blood pressure medications experience a significant increase in hypotensive events, including severe dizziness, fainting, a...
A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.
MONDAY, June 15, 2026 — Researchers are flagging a potential safety concern tied to GLP-1 medications and blood pressure. A new Northwestern Medicine study tracked more than 42,000...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.